» Articles » PMID: 19833906

Upregulation of Monocyte/macrophage HGFIN (Gpnmb/Osteoactivin) Expression in End-stage Renal Disease

Overview
Specialty Nephrology
Date 2009 Oct 17
PMID 19833906
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: Hematopoietic growth factor-inducible neurokinin 1 (HGFIN), also known as Gpnmb and osteoactivin, is a transmembrane glycoprotein that is expressed in numerous cells, including osteoclasts, macrophages, and dendritic cells. It serves as an osteoblast differentiation factor, participates in bone mineralization, and functions as a negative regulator of inflammation in macrophages. Although measurable at low levels in monocytes, monocyte-to-macrophage transformation causes substantial increase in HGFIN expression. HGFIN is involved in systemic inflammation, bone demineralization, and soft tissue vascular calcification.

Design, Setting, Participants, & Measurements: We explored HGFIN expression in monocytes and monocyte-derived macrophages in 21 stable hemodialysis patients and 22 control subjects.

Results: Dialysis patients exhibited marked upregulation of colony-stimulating factor and IL-6 and significant downregulation of IL-10 in intact monocytes and transformed macrophages. HGFIN expression in intact monocytes was negligible in control subjects but conspicuously elevated (8.6-fold) in dialysis patients. As expected, in vitro monocyte-to-macrophage transformation resulted in marked upregulation of HGFIN in cells obtained from both groups but much more so in dialysis patients (17.5-fold higher). Upregulation of HGFIN and inflammatory cytokines in the uremic monocyte-derived macrophages occurred when grown in the presence of either normal or uremic serum, suggesting the enduring effect of the in vivo uremic milieu on monocyte/macrophage phenotype and function.

Conclusions: Uremic macrophages exhibit increased HGFIN gene and protein expression and heightened expression of proinflammatory and a suppressed expression of anti-inflammatory cytokines. Further studies are needed to determine the role of heightened monocyte/macrophage HGFIN expression in the pathogenesis of ESRD-induced inflammation and vascular and soft tissue calcification.

Citing Articles

The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies.

Tang Z, Yu S, Pan Y J Transl Med. 2023; 21(1):689.

PMID: 37789439 PMC: 10546717. DOI: 10.1186/s12967-023-04455-2.


Lineage-Selective Disturbance of Early Human Hematopoietic Progenitor Cell Differentiation by the Commonly Used Plasticizer Di-2-ethylhexyl Phthalate via Reactive Oxygen Species: Fatty Acid Oxidation Makes the Difference.

Kaiser L, Quint I, Csuk R, Jung M, Deigner H Cells. 2021; 10(10).

PMID: 34685682 PMC: 8534767. DOI: 10.3390/cells10102703.


The Role of GPNMB in Inflammation.

Saade M, de Souza G, Scavone C, Kinoshita P Front Immunol. 2021; 12:674739.

PMID: 34054862 PMC: 8149902. DOI: 10.3389/fimmu.2021.674739.


Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.

Tsou P, Sawalha A FASEB J. 2020; 34(7):8810-8823.

PMID: 32445534 PMC: 7501235. DOI: 10.1096/fj.202000651.


Glycoprotein non-metastatic melanoma B expression after hepatic ischemia reperfusion and the effect of silibinin.

Michalinos A, Tsaroucha A, Lambropoulou M, Schizas D, Valsami G, Kostomitsopoulos N Transl Gastroenterol Hepatol. 2020; 5:7.

PMID: 32190775 PMC: 7061179. DOI: 10.21037/tgh.2019.11.01.


References
1.
Porazko T, Kuzniar J, Kusztal M, Kuzniar T, Weyde W, Kuriata-Kordek M . IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant. 2008; 24(2):589-96. DOI: 10.1093/ndt/gfn486. View

2.
Selim A, Abdelmagid S, Kanaan R, Smock S, Owen T, Popoff S . Anti-osteoactivin antibody inhibits osteoblast differentiation and function in vitro. Crit Rev Eukaryot Gene Expr. 2003; 13(2-4):265-75. DOI: 10.1615/critreveukaryotgeneexpr.v13.i24.180. View

3.
Jean G, Bresson E, Terrat J, Vanel T, Hurot J, Lorriaux C . Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2008; 24(3):948-55. DOI: 10.1093/ndt/gfn571. View

4.
Kovesdy C, Kalantar-Zadeh K . Novel targets and new potential: developments in the treatment of inflammation in chronic kidney disease. Expert Opin Investig Drugs. 2008; 17(4):451-67. PMC: 5500838. DOI: 10.1517/13543784.17.4.451. View

5.
Bostrom K, Watson K, Horn S, Wortham C, Herman I, Demer L . Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993; 91(4):1800-9. PMC: 288161. DOI: 10.1172/JCI116391. View